American Journal of Health-System Pharmacy

Wolters Kluwer acquires U.S. AI-enabled drug diversion detection software

Retrieved on: 
Wednesday, June 7, 2023
Wolters Kluwer, American Journal of Health-System Pharmacy, GA, Pharmacy, National Institutes of Health, Bangladesh Technical Education Board, Plasma protein binding, Public health surveillance, Hospital, Acquisition, Risk, Machine learning, MA, Health, Behavior, Safety, Drug, Medical device

Technology leader seeks to help tackle growing drug diversion challenge in the U.S.

Key Points: 
  • Technology leader seeks to help tackle growing drug diversion challenge in the U.S.
    Waltham, MA – June 7, 2023 – Wolters Kluwer Health today announced it has signed and completed the acquisition of Invistics Corporation (Invistics), a U.S.-based provider of cloud-based, AI-enabled software for drug diversion detection and controlled substance compliance.
  • Drug diversion is a growing challenge in the U.S. healthcare system, costing some $70 billion per year.
  • Flowlytics reconciles drug transactions from purchase to patient and uses AI to rapidly and accurately identify patterns of behavior consistent with drug diversion.
  • A five-year National Institutes of Health-funded study found that Flowlytics detected cases of drug diversion faster and with more efficiency than legacy solutions.² In addition to detection, the solution also supports diversion investigation, adjudication, and reporting workflows.

Wolters Kluwer acquires U.S. AI-enabled drug diversion detection software

Retrieved on: 
Wednesday, June 7, 2023
Public Policy, Government, Software, Pharmaceutical, Health, Law Enforcement, Emergency Services, Artificial Intelligence, Technology, Apps, Applications, American Journal of Health-System Pharmacy, GA, Pharmacy, National Institutes of Health, Bangladesh Technical Education Board, MS, Plasma protein binding, Public health surveillance, Hospital, Acquisition, Risk, Machine learning, Wolters Kluwer, Behavior, Safety, Medical device

Wolters Kluwer Health today announced it has signed and completed the acquisition of Invistics Corporation (Invistics), a U.S.-based provider of cloud-based, AI-enabled software for drug diversion detection and controlled substance compliance.

Key Points: 
  • Wolters Kluwer Health today announced it has signed and completed the acquisition of Invistics Corporation (Invistics), a U.S.-based provider of cloud-based, AI-enabled software for drug diversion detection and controlled substance compliance.
  • Drug diversion is a growing challenge in the U.S. healthcare system, costing some $70 billion per year.
  • Flowlytics reconciles drug transactions from purchase to patient and uses AI to rapidly and accurately identify patterns of behavior consistent with drug diversion.
  • A five-year National Institutes of Health-funded study found that Flowlytics detected cases of drug diversion faster and with more efficiency than legacy solutions.² In addition to detection, the solution also supports diversion investigation, adjudication, and reporting workflows.

Research by Husson Pharmacy Faculty and PCHC Colleague Describes Second-Year Pharmacy Residency Growth

Retrieved on: 
Thursday, March 9, 2023
Humanities, School, ASHP, U.S. News & World Report, Science, Hospital, News, Addition Financial, American Journal, Student, Business administration, Education, Physical therapy, Doctor of Pharmacy, Research, UCL School of Pharmacy, Volume, American Journal of Health-System Pharmacy, Boston School of Occupational Therapy, Growth, Master of Business Administration, Occupational therapy, MBA, University of Virginia School of Nursing, Faculty, Health, Society, BCPS, Attention, Nursing care plan, Ambulatory care, Husson University, National Resident Matching Program, American Society of Health-System Pharmacists, College, BCPP, Communication, Nursing, Soft drink, Pharmacy

The research was completed by two faculty members from the Husson University School of Pharmacy.

Key Points: 
  • The research was completed by two faculty members from the Husson University School of Pharmacy.
  • They are Dr. Drew Lambert, BCPS, an associate professor of pharmacy practice and Dr. Shannon M. James, BCPP, an assistant professor of pharmacy practice.
  • Prior to joining PCHC , Welch was an assistant professor of pharmacy practice at Husson’s School of Pharmacy from August 2019 - August 2021.
  • The School of Pharmacy is just one of several schools that are a part of Husson University’s College of Health and Pharmacy.

NCCN Pharmacy Directors Forum Publishes Recommendations for Safely Dispensing Investigational Medications for Clinical Trials

Retrieved on: 
Tuesday, March 15, 2022
Twitter, Decision-making, University, Education, Patient, Journal of the National Comprehensive Cancer Network, Assistant director, Pharmacy, National Comprehensive Cancer Network, American Journal of Health-System Pharmacy, Doctor of Pharmacy, IDS, Safety, NCCN, Caregiver, The James Cancer Hospital, MD Anderson Cancer Center, Medicine, Clinical trial, Pharmacist, Research, Cancer, Health, American Journal, Efficiency, Policy, Pharmaceutical industry, Dietary supplement

These new recommendations come from an Investigational Drug Services (IDS) work group that arose out of the NCCN Pharmacy Directors Forum.

Key Points: 
  • These new recommendations come from an Investigational Drug Services (IDS) work group that arose out of the NCCN Pharmacy Directors Forum.
  • "Promoting standardization and establishing robust IDS policies and procedures will help improve the feasibility of opening and successfully operating clinical trials.
  • "Clinical trials are increasing in complexity and logistics," agreed NCCN Work Group Co- Lead Sapna Amin, PharmD, Manager, Investigational Pharmacy Services, The University of Texas MD Anderson Cancer Center.
  • Visit NCCN.org for more information and follow NCCN on Facebook @NCCNorg , Instagram @NCCNorg , and Twitter @NCCN .

Healthcare Drug Diversion Detected Faster, More Accurately with Advanced Analytics/Machine Learning Software, AJHP Study Finds

Retrieved on: 
Thursday, March 3, 2022
Machine learning, Movement, Bernie May, Patient, Data, Research, Hospital, National, American Journal of Health-System Pharmacy, Safety, Principal, Anesthesia, LLC, Scripps Health, Efficiency, Compliance, CEO, Executive, National Institute, Nursing, Technology, National Institute on Drug Abuse, American Journal, Medical device, Health insurance, Medicine, Pharmacy

Researchers then gauged when the machine learning model would have found, or detected, evidence of those known diversion cases.

Key Points: 
  • Researchers then gauged when the machine learning model would have found, or detected, evidence of those known diversion cases.
  • The advanced analytics and machine learning technologies detected known diversion cases (n=22) in blinded data an average of 160 days faster than existing, non-machine learning detection methods had.
  • Additionally, the machine learning model demonstrated 96.3% accuracy, 95.9% specificity, and 96.6% sensitivity detecting transactions at high-risk of diversion in the dataset.
  • Drug diversion in healthcare settings is a silent, yet pervasive epidemic with financial, clinical, and legal consequences.

Research Led by FDB Pharmacists and Health System Clinicians Further Shatters Age-Old Iodine Allergy Myth

Retrieved on: 
Wednesday, September 15, 2021
Precision medicine, Patient safety, Anaphylaxis, Food, Prescription, SAN, American Academy, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, FDB, FDA, Steroid, Decision-making, Pharmacist, Shellfish, Seafood, Pharmacy, Mayo Clinic, Doctor of Pharmacy, MHK, Patient, Degenerative disease, Allergy, Thyroid, Society, MCG, Pharmacy management system, BCPS, YouTube, LinkedIn, Trauma, Neoplasm, Safety, Dehydration, Physician, Iodine, Solution, MD, Hearst, American Journal of Health-System Pharmacy, Asthma, Amiodarone, First Databank, Twitter, Blood, American Journal, American Academy of Allergy, Asthma, and Immunology, Radiology, Povidone-iodine, Hospital, Rash, Face, Agent handling, Research, Cancer, Tongue, American College, Sudarshan K. Aggarwal, Pharmaceutical industry, Medical imaging

The findings were recently published in the American Journal of Health-System Pharmacy , a peer-reviewed journal of the American Society of Health-System Pharmacists.

Key Points: 
  • The findings were recently published in the American Journal of Health-System Pharmacy , a peer-reviewed journal of the American Society of Health-System Pharmacists.
  • Sixty-six percent to 89% of physicians routinely ask patients prior to an imaging test if they have an iodine allergy or an allergy to shellfish or other seafood that may contain iodine.
  • FDB (First Databank) is the leading provider of drug and medical device knowledge that helps healthcare professionals make precise decisions.
  • The Hearst Health network includes FDB (First Databank), Zynx Health , MCG , Homecare Homebase and MHK (formerly MedHOK).